Burlington County Public Health Profile Report
Incidence of Leukemia: Age-Adjusted Rate per 100,000 Males, 2014-2018
Burlington22.8 95% Confidence Interval(20.2 - 25.8)Description of the Confidence IntervalThe confidence interval indicates the range of probable true values for the level of risk in the community.
A value of "NA" (Not Available) will appear if the confidence interval was not published with the NJSHAD indicator data for this measure.
State20.4 U.S. NANA=Data not available.
Burlington Compared to State
Description of Gauge
Description of the GaugeThis graphic is based on the county data to the left. It compares the county value of this indicator to the state overall value.
The county value is considered statistically significantly different from the state value if the state value is outside the range of the county's 95% confidence interval. If the county's data or 95% confidence interval information is not available, a blank gauge image will be displayed with the message, "missing information."NOTE: The labels used on the gauge graphic are meant to describe the county's status in plain language. The placement of the gauge needle is based solely on the statistical difference between the county and state values. When selecting priority health issues to work on, a county should take into account additional factors such as how much improvement could be made, the U.S. value, the statistical stability of the county number, the severity of the health condition, and whether the difference is clinically significant.
- Excellent = The county's value on this indicator is BETTER than the state value, and the difference IS statistically significant.
- Watch = The county's value is BETTER than state value, but the difference IS NOT statistically significant.
- Improvement Needed = The county's value on this indicator is WORSE than the state value, but the difference IS NOT statistically significant.
- Reason for Concern = The county's value on this indicator is WORSE than the state value, and the difference IS statistically significant.
Why Is This Important?During 2018, 943 New Jersey males and 678 females of all ages were diagnosed with leukemias. At this time, we do not know what causes most leukemias.
How Are We Doing?The four most common types of leukemias occur with differing frequencies in adults versus children. Acute lymphocytic leukemia (ALL) is the most common type of childhood leukemia and also affects adults, especially those age 65 and older. Acute myeloid leukemia (AML) occurs in both adults and children. Chronic lymphocytic leukemia most commonly affects adults over age 55, and rarely occurs in children. Chronic myeloid leukemia (CML) occurs mainly in adults. Leukemia incidence rates and counts by age group are provided for the four most common types of leukemia. Detailed incidence rates and counts by gender and county are provided for the two most common types of leukemia (AML and CLL). Although it is often thought of as a children's disease, most cases of leukemia occur in older adults. Leukemia is ten times more common in adults than in children, and more than half of all leukemia cases occur in people over the age of 65. The lifetime risk of developing leukemia is 1 in 54 for men and 1 in 78 for women.
What Is Being Done?A Comprehensive Cancer Control Plan was developed by the Task Force on Cancer Prevention, Early Detection and Treatment in New Jersey which aims to reduce the incidence, illness and death due to cancer among New Jersey residents. [https://www.cdc.gov/cancer/ncccp/ccc_plans.htm]
Health Status Outcomes:
NoteIncidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ..., 80-84, 85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Number of cases (numerator) is the total count of cases in five years.
Data SourcesNJ State Cancer Registry, Nov 16, 2020 Analytic File, using NCI SEER*Stat ver. 8.3.9, [https://seer.cancer.gov/seerstat/] NJ population estimates as calculated by the NCI's SEER Program, released February 2021, [https://www.seer.cancer.gov/popdata/download.html]
Measure Description for Incidence of Leukemia
Definition: Incidence rate of leukemia by sub-type for a defined population in a specified time interval. Rates are age-adjusted to the 2000 U.S. Standard Population. Rates are per 100,000 population.
Numerator: Number of new cases of leukemia by sub-type among a defined population in a specified time interval.
Denominator: Defined population in a specified time interval.